Encompass Health (NYSE:EHC) Issues FY 2026 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 5.810-6.100 for the period, compared to the consensus EPS estimate of 5.820. The company issued revenue guidance of $6.4 billion-$6.5 billion, compared to the consensus revenue estimate of $6.4 billion.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Barclays lifted their target price on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Finally, Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and an average price target of $142.86.

Encompass Health Price Performance

Shares of NYSE:EHC traded up $3.88 on Thursday, reaching $99.54. The company’s stock had a trading volume of 2,840,980 shares, compared to its average volume of 1,297,216. The company has a 50-day simple moving average of $104.81 and a 200 day simple moving average of $114.55. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. The company has a market cap of $10.02 billion, a P/E ratio of 18.82, a PEG ratio of 1.52 and a beta of 0.73. Encompass Health has a 52-week low of $92.53 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.29 by $0.17. The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities research analysts anticipate that Encompass Health will post 4.8 EPS for the current fiscal year.

Institutional Investors Weigh In On Encompass Health

Institutional investors and hedge funds have recently bought and sold shares of the company. EP Wealth Advisors LLC grew its holdings in Encompass Health by 2.4% in the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after purchasing an additional 88 shares during the last quarter. Ancora Advisors LLC lifted its stake in Encompass Health by 0.3% during the third quarter. Ancora Advisors LLC now owns 47,688 shares of the company’s stock worth $6,057,000 after purchasing an additional 160 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Encompass Health by 0.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 33,450 shares of the company’s stock valued at $4,249,000 after buying an additional 187 shares during the period. Van ECK Associates Corp lifted its stake in Encompass Health by 0.3% during the 3rd quarter. Van ECK Associates Corp now owns 78,011 shares of the company’s stock worth $9,909,000 after acquiring an additional 266 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after purchasing an additional 362 shares during the period. 97.25% of the stock is owned by institutional investors.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.